Learn More


“Working closely with global industry leaders– including major universities, governments, private and not-for profit organizations–we have proven that we can ultimately create globally accepted standards without boundaries, moving our industry to become more efficient by breaking down the silos and non-collaborative models,” said Al O. Pacino, President, HealthCarePoint. “Our collaborative approach eliminates redundant burdens at the investigator site level, saving industry stakeholders billions, as regulatory agencies continue to require increased proof of competencies and professional compliance.”

When NINDS produced a full and accurate, high quality program for the NIH Stroke Scale in 2002, we knew it was something the research community badly needed. But I don’t think we could have ever dreamed that the program would reach this many people. We are impressed by the fact that this important medical tool has been made available globally, and to so many disciplines,” said Walter J. Koroshetz, M.D., Deputy Director of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.

“As the most successful training and certification program, the NIHSS International illustrates how other programs can achieve global acceptance. By combining programs like the NIHSS into global healthcare and clinical research, we could ultimately improve outcomes as all healthcare providers learn to diagnose patients the same way–in a standardized fashion.” Patrick Lyden, MD, FAAN, FAHA, Chairman, Department of Neurology Carmen and Louis Warschaw Chairin Neurology Cedars-SinaiMedical Center.

“The Portuguese language is spoken by 244 million people worldwide. The NIHSS certification has become a vastly important initiative, allowing healthcare providers to transnationally use the instrument as a standard of care, ultimately leading to better outcomes for stroke patients.” Elsa Azevedo, MD, PhD, São João Hospital Center, University of Porto, Portugal; Pedro Castro, MD, São João Hospital Center, University of Porto.

"The NIHSS is used widely In the Netherlands during trials. Now we have the opportunity to promote its use in routine care by certified ER personnel, stroke nurses and neurologists, and I am convinced that this will improve the care and clinical outcomes of our stroke patients.” Diederik W J Dippel, MD, Prof, Erasmus MC University Medical Center.

“Spanish is spoken by nearly 406 million people in 31 countries. Not only has the Spanish-NIHSS become widely used across most of the Spanish-speaking world, it has also become a unifying tool for research, stroke registers, quality control and every day clinical work. We are very proud of being a part of this global effort.” Arnold Hoppe, MD, Director Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiagode Chile.

“When the Italian-NIHSS became public, we thought we would be helping Italian stroke physicians and nurses to improve their ability to use the scale in the proper way. Over the years, we came to realize that NIHSS is not only a scale, it now belongs to a new vision of modern stroke care!” Francesca Romana Pezzella, MD, PhD, MSc Stroke Unit, DEM, AOS St Camillo Forlanini, Roma.

“Stroke is a major health concern in Malaysia due to the steady increase in the prevalence of vascular risk factors and a growing number of elderly. Thrombolysis for stroke is in its early days in Malaysia. Because access to the standardized program is free, it should become more wide spread among healthcare providers, just as it has in other countries, and hopefully will lead to a reduction in assessment delays and improved patient care.” Ramesh Sahathevan, MD, Ph. D, MRCP, M. Med, University Kebangsaan, Malaysia Medical Centre.

“Sharing our BlueCloud Delivery, Distribution, Implementation and Tracking (DDIT) sustainable innovations, intellectual property, including our delivery vehicles and our proprietary database methodologies, has proven to be a successful collaborative model to help modernize the world of healthcare and clinical research. With the help of champion collaborators, programs like the NIHSS can be delivered to healthcare providers around using our DDIT innovations the world without added financial burdens to the ecosystem because ☆ NO PATIENT SHOULD BE LEFT BEHIND ☆. Our goal is to continue our collaborative efforts so that all organizations and their patients can have an equal opportunity to participate in our global healthcare and clinical research ecosystem, learn best practices and ultimately offer the best possible standards of care, with a common global mission to modernize the healthcare and clinical research system so that no patient is left behind no matter what race, religion, socio-economic status, political affiliation or geographical area by empowering and incentivizing people and businesses to share their information for business and compliance.” Al O. Pacino, President, HealthCarePoint.